Abstract
Background:Prior reports have shown the utility of conventional lipiodol-based transarterial chemoembolization in hepatoblastoma. The authors describe the first reported case of hepatoblastoma treated with drug-eluting bead transarterial chemoembolization (DEB-TACE).Observations:An 11-month-old infant presented with hepatoblastoma measuring 14.3 cm. A trial of cisplatin chemotherapy followed by sequential DEB-TACE to the tumor's feeding vasculature reduced the mass to 5.3 cm. The patient tolerated both sessions of DEB-TACE without any major complication. Having demonstrated adequate disease control, the patient then underwent successful liver transplantation.Conclusion:This report provides promising evidence for the treatment of hepatoblastoma with DEB-TACE.
Original language | English (US) |
---|---|
Pages (from-to) | E123-E126 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 43 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2021 |
Keywords
- DEB-TACE
- hepatoblastoma
- interventional oncology
- interventional radiology
ASJC Scopus subject areas
- Hematology
- Oncology
- Pediatrics, Perinatology, and Child Health